Roivant, Arbutus Biopharma stocks surges on $2.25B Moderna settlement

Investing.com Gold reports: Roivant, Arbutus Biopharma stocks surges on $2.25B Moderna settlement. This is a premium/paywalled source, so the brief is based on headline and available metadata only.